Hysingla ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Purdue Pharma Lp. The primary component is Hydrocodone Bitartrate.
Product ID | 59011-271_1f1ceab3-0084-d944-a84f-1344873c39fd |
NDC | 59011-271 |
Product Type | Human Prescription Drug |
Proprietary Name | Hysingla ER |
Generic Name | Hydrocodone Bitartrate |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2015-01-15 |
Marketing Category | NDA / NDA |
Application Number | NDA206627 |
Labeler Name | Purdue Pharma LP |
Substance Name | HYDROCODONE BITARTRATE |
Active Ingredient Strength | 20 mg/1 |
Pharm Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2015-01-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206627 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-15 |
Ingredient | Strength |
---|---|
HYDROCODONE BITARTRATE | 20 mg/1 |
SPL SET ID: | b7d23ac2-e776-9f62-3290-c64c2d6eb353 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
59011-276 | Hysingla ER | Hysingla ER |
59011-272 | Hysingla ER | Hysingla ER |
59011-273 | Hysingla ER | Hysingla ER |
59011-275 | Hysingla ER | Hysingla ER |
59011-274 | Hysingla ER | Hysingla ER |
59011-277 | Hysingla ER | Hysingla ER |
59011-271 | Hysingla ER | Hysingla ER |
47781-392 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-393 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-394 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-395 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-396 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-397 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-398 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-409 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-410 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-411 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-412 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-413 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
47781-414 | Hydrocodone Bitartrate | Hydrocodone Bitartrate |
43376-210 | Zohydro | hydrocodone bitartrate |
43376-215 | Zohydro | hydrocodone bitartrate |
43376-220 | Zohydro | hydrocodone bitartrate |
43376-230 | Zohydro | hydrocodone bitartrate |
43376-240 | Zohydro | hydrocodone bitartrate |
43376-250 | Zohydro | hydrocodone bitartrate |
43376-310 | Zohydro | hydrocodone bitartrate |
43376-315 | Zohydro | hydrocodone bitartrate |
43376-320 | Zohydro | hydrocodone bitartrate |
43376-330 | Zohydro | hydrocodone bitartrate |
43376-340 | Zohydro | hydrocodone bitartrate |
43376-350 | Zohydro | hydrocodone bitartrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HYSINGLA ER 86446650 not registered Dead/Abandoned |
Purdue Pharma L.P. 2014-11-06 |
HYSINGLA ER 86242700 4713945 Live/Registered |
Purdue Pharma L.P. 2014-04-04 |